Amgen, Zai Lab succeed in gastric cancer study
Source: SeekingAlpha
2025-06-30 11:00:20 ET
More on Amgen, Zai Lab
- Amgen Inc. (AMGN) Presents at Special Call (IR Call) Conference Transcript
- American Diabetes Association 85th Scientific Session
- Amgen: Imdelltra Data And Q1 Results Impress
- Amgen falls despite positive weight loss trial results
- Lilly, Novo, and Amgen set for key obesity trial readouts at ongoing ADA event
Read the full article on Seeking Alpha
For further details see:
Amgen, Zai Lab succeed in gastric cancer study
Amgen Inc.
NASDAQ: AMGN
AMGN Trading
-1.04% G/L:
$367.03 Last:
497,785 Volume:
$370.68 Open:
AMGN Latest News
March 05, 2026 04:01:00 pm
AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE
AMGN Stock Data
$198,734,368,843
533,095,864
0.02%
1871
N/A
Pharmaceuticals
Healthcare
US
Thousand Oaks
